Ameriprise’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.2M Sell
901,138
-3,180
-0.4% -$70.3K ﹤0.01% 1519
2025
Q4
$21.9M Sell
904,318
-4,583
-0.5% -$120K ﹤0.01% 1352
2025
Q3
$23.2M Sell
908,901
-171,470
-16% -$4.07M 0.01% 1290
2025
Q2
$23.3M Buy
1,080,371
+109,959
+11% +$2.48M 0.01% 1254
2025
Q1
$22.2M Buy
970,412
+131,307
+16% +$3.46M 0.01% 1246
2024
Q4
$21.8M Sell
839,105
-4,123
-0.5% -$103K 0.01% 1277
2024
Q3
$21.1M Sell
843,228
-264,082
-24% -$6.24M 0.01% 1301
2024
Q2
$23.7M Sell
1,107,310
-6,178
-0.6% -$120K 0.01% 1173
2024
Q1
$20.7M Sell
1,113,488
-285,784
-20% -$5M 0.01% 1274
2023
Q4
$22.7M Buy
1,399,272
+866,906
+163% +$11.1M 0.01% 1198
2023
Q3
$7.35M Sell
532,366
-428,745
-45% -$6.76M ﹤0.01% 1959
2023
Q2
$21.2M Sell
961,111
-2,976
-0.3% -$62.7K 0.01% 1215
2023
Q1
$21M Sell
964,087
-166,156
-15% -$3.74M 0.01% 1224
2022
Q4
$20.6M Buy
1,130,243
+10,959
+1% +$226K 0.01% 1212
2022
Q3
$25.5M Buy
1,119,284
+39,362
+4% +$842K 0.01% 1038
2022
Q2
$14.9M Buy
1,079,922
+7,574
+0.7% +$111K 0.01% 1432
2022
Q1
$24.4M Sell
1,072,348
-2,971
-0.3% -$78.2K 0.01% 1204
2021
Q4
$40.1M Buy
1,075,319
+31,712
+3% +$1.36M 0.01% 948
2021
Q3
$44.2M Buy
1,043,607
+124,606
+14% +$6M 0.01% 822
2021
Q2
$40.9M Buy
919,001
+1,220
+0.1% +$43K 0.01% 896
2021
Q1
$33M Buy
917,781
+903
+0.1% +$35.7K 0.01% 983
2020
Q4
$36.6M Buy
916,878
+8,682
+1% +$296K 0.01% 887
2020
Q3
$26.3M Buy
908,196
+69,735
+8% +$1.51M 0.01% 935
2020
Q2
$13.7M Buy
838,461
+88,719
+12% +$1.22M 0.01% 1306
2020
Q1
$7.12M Buy
749,742
+149,165
+25% +$2.05M ﹤0.01% 1650
2019
Q4
$9.72M Buy
600,577
+52,277
+10% +$850K ﹤0.01% 1769
2019
Q3
$9.12M Buy
548,300
+335,403
+158% +$6.29M ﹤0.01% 1777
2019
Q2
$3.61M Buy
212,897
+38,104
+22% +$664K ﹤0.01% 2433
2019
Q1
$3.13M Buy
174,793
+72,482
+71% +$1.15M ﹤0.01% 2515
2018
Q4
$1.23M Buy
+102,311
New +$1.22M ﹤0.01% 2858

Other funds holding BLFS